KHK 4827

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KHK 4827, covering 2023-08-25 to 2023-08-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Clinical Study of KHK 4827 [Phase 3]